<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medinfo</journal-id><journal-title-group><journal-title xml:lang="ru">Актуальные проблемы теоретической и клинической медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Actual Problems of Theoretical and Clinical Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2790-1289</issn><issn pub-type="epub">2790-1297</issn><publisher><publisher-name>Казахстанско-Российский медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24412/2790-1289-2024-3-46-67</article-id><article-id custom-type="elpub" pub-id-type="custom">medinfo-421</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVEWS</subject></subj-group></article-categories><title-group><article-title>Новый подход к медицинской реабилитации и паллиативной помощи пациентам с онкопатологией в контексте интегративной медицины</article-title><trans-title-group xml:lang="en"><trans-title>A new approach to medical rehabilitation and palliative care for patients with oncology in the context of integrative medicine</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0596-8777</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Панов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Panov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Панов Станислав Александрович – к.м.н., д.ф. (PhD), профессор</p></bio><bio xml:lang="en"><p>Panov Stanislav Alexandrovich – Candidate of Medical Sciences, PhD, Professor</p></bio><email xlink:type="simple">panov_stanislav@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-1660-5439</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Балтабеков</surname><given-names>Н. Т.</given-names></name><name name-style="western" xml:lang="en"><surname>Baltabekov</surname><given-names>N. T.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Балтабеков Нурлан Турсунович – д.м.н., профессор</p></bio><bio xml:lang="en"><p>Baltabekov Nurlan Tursunovich – Doctor of Medical Sciences, Professor</p></bio><email xlink:type="simple">baltabekov@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0007-6098-8056</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлюков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlyukov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Павлюков Андрей Викторович</p></bio><bio xml:lang="en"><p>Pavlyukov Andrey Viktorovich</p></bio><email xlink:type="simple">andrei19791508@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4051-0908</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Палтушев</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Paltushev</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Палтушев Абдували Абдумухаметович</p></bio><bio xml:lang="en"><p>Paltushev Abduvali Abdumukhametovich</p></bio><email xlink:type="simple">pal2sheff@hotmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нургалиев</surname><given-names>Б. Э.</given-names></name><name name-style="western" xml:lang="en"><surname>Nurgaliev</surname><given-names>B. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нургалиев Бауржан Эсенгельдиевич</p></bio><bio xml:lang="en"><p>Nurgaliev Baurzhan Esengeldievich</p></bio><email xlink:type="simple">Nurgaliev-b@hotmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-6501-5033</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рысбаев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rysbaev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Рысбаев Аскар Васильевич</p></bio><bio xml:lang="en"><p>Rysbaev Askar Vasilyevich</p></bio><email xlink:type="simple">rysbaev-a@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Военный клинический госпиталь Министерства обороны Республики Казахстан<country>Казахстан</country></aff><aff xml:lang="en">Military Clinical Hospital of the Ministry of Defense of the Republic of Kazakhstan<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">Научно-исследовательский международный институт последипломного образования<country>Казахстан</country></aff><aff xml:lang="en">International Research Institute of Postgraduate Education<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">Военно-медицинское управление Министерства обороны Республики Казахстан<country>Казахстан</country></aff><aff xml:lang="en">Military Medical Department of the Ministry of Defense of the Republic of Kazakhstan<country>Kazakhstan</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">Главный Военный клинический госпиталь Министерства обороны Республики Казахстан<country>Казахстан</country></aff><aff xml:lang="en">The Main Military Clinical Hospital of the Ministry of Defense of the Republic of Kazakhstan<country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>02</day><month>09</month><year>2024</year></pub-date><volume>0</volume><issue>3</issue><fpage>46</fpage><lpage>66</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Панов С.А., Балтабеков Н.Т., Павлюков А.В., Палтушев А.А., Нургалиев Б.Э., Рысбаев А.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Панов С.А., Балтабеков Н.Т., Павлюков А.В., Палтушев А.А., Нургалиев Б.Э., Рысбаев А.В.</copyright-holder><copyright-holder xml:lang="en">Panov S.A., Baltabekov N.T., Pavlyukov A.V., Paltushev A.A., Nurgaliev B.E., Rysbaev A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://kazrosmedjournal.krmu.edu.kz/jour/article/view/421">https://kazrosmedjournal.krmu.edu.kz/jour/article/view/421</self-uri><abstract><p>В систематическом обзоре обобщены современные исследования влияния растительных фенолов и некоторых лекарственных препаратов на внутриклеточный биохимический каскад в процессе формирования противоракового иммунитета. Кроме того, в нем исследуются потенциальные клинически доступные методы оценки иммунитета, которые могут быть применены в контексте интегративной медицины для персонализации реабилитационной терапии онкологических больных после химиотерапии и хирургического вмешательства.Глубина поиска составляет 6 лет (с 2017 г. до 2023 г.). В поиск включены исследования из рецензируемых журналов и не рецензируемых публикаций. Систематический обзор в основном включает фундаментальные исследования и обзорные статьи, размещенные в шести электронных базах данных: PubMed/MEDLINE, Кокрейновская библиотека, Science Direct, Google Scholar, eLIBRARY, Web of Science.В результате отобраны 64 исследования, из которых 29 были оригинальными (11 исследований на животных, 8 исследований на клеточных культурах и 10 исследований на 1344 взрослых людях). Для правильного подбора схемы питания и восстановительной терапии очень важнообращать внимание на состояние физиологического стресса, степень дисфункции митохондрий, количественное и качественное состояние нейтрофилов и лимфоцитов. На основании этих показателей можно достоверно персонализировать дозы, сроки терапии и контролировать эффективность. Оказалось, что иммунная система устроена еще сложнее, чем нервная и функциональная активность лейкоцитов может отражать также и гомеостаз всего внутреннего мира человека, а по состоянию функции гранулоцитов можно судить о функции большинства клеток целого организма и оценивать «иммунологический контроль опухоли» в ключе состояния «микроокружения опухоли», предложенный Eggermont AMM</p></abstract><trans-abstract xml:lang="en"><p>The systematic review summarizes modern studies of the effect of plant phenols and certain drugs on the intracellular biochemical cascade in the formation of anti-cancer immunity. In addition, it explores potential clinically available methods for assessing immunity that can be applied in the context of integrative medicine to personalize rehabilitation therapy for cancer patients after chemotherapy and surgery.The search depth is 6 years (from 2017 to 2023). The search includes research from peer-reviewed journals and non-peer-reviewed publications. The systematic review mainly includes basic research and review articles published in six electronic databases: PubMed/MEDLINE (https://pubmed.ncbi.nlm.nih.gov/), The Cochrane Library (https://www.cochranelibrary.com/), ScienceDirect (https://www.sciencedirect.com/), Google Scholar (https://scholar.google.com.mx /), eLibrary (https://elibrary.ru/), Web of Science (https://www.webofscience.com/).As a result, 64 studies were selected, of which 29 were original (11 animal studies, 8 cell culture studies and 10 studies on 1,344 adults).Conclusions. For the correct selection of a nutrition regimen and rehabilitation therapy, it is very important to pay attention to the state of physiological stress, the degree of mitochondrial dysfunction, the quantitative and qualitative state of neutrophils and lymphocytes. Based on these indicators, it is possible to reliably personalize the dose, the duration of therapy and monitor the effectiveness. It turned out that the immune system is even more complicated than the nervous and functional activity of leukocytes can also reflect the homeostasis of the entire inner world of a person, and according to the state of granulocyte function, it is possible to judge the function of most cells of the whole organism and evaluate the «immunological control of the tumor» in the key of the state of the "tumor microenvironment" proposed by Eggermont AMM.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>интегративная медицина</kwd><kwd>макрофаги</kwd><kwd>Т-клетки</kwd><kwd>химиотерапия</kwd><kwd>рак</kwd><kwd>CpG</kwd><kwd>CD47</kwd><kwd>функциональная оценка нейтрофилов</kwd></kwd-group><kwd-group xml:lang="en"><kwd>integrative medicine</kwd><kwd>macrophages</kwd><kwd>T cells</kwd><kwd>chemotherapy</kwd><kwd>cancer</kwd><kwd>CpG</kwd><kwd>CD47</kwd><kwd>functional assessment of neutrophils</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kroemer G. et al. Immunosurveillance in clinical cancer management // CA: A Cancer Journal for Clinicians. – 2024. – Т. 74. – Vol. 2. – P. 187-202.</mixed-citation><mixed-citation xml:lang="en">Kroemer G. et al. Immunosurveillance in clinical cancer management // CA: A Cancer Journal for Clinicians. – 2024. – Т. 74. – Vol. 2. – P. 187-202.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Chhikara B. S., Parang K. Global Cancer Statistics 2022: the trends projection analysis // Chemical Biology Letters. – 2023. – Т. 10. – Vol. 1. – P. 451-451.</mixed-citation><mixed-citation xml:lang="en">Chhikara B. S., Parang K. Global Cancer Statistics 2022: the trends projection analysis // Chemical Biology Letters. – 2023. – Т. 10. – Vol. 1. – P. 451-451.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Шаназаров Н. А. и др. Возможности и проблемы современной реабилитации в онкологии // Фундаментальные исследования. – 2015. – № 1-8. – С. 1735-1740.</mixed-citation><mixed-citation xml:lang="en">Shanazarov, N. A. et al. (2015). Vozmozhnosti i problemy sovremennoj reabilitacii v onkologii. Basic research, 1-8, 1735-1740. (In Russion).</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Sharma N., Vacher J., Allison J. P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion // Proceedings of the National Academy of Sciences. – 2019. – Т. 116. – Vol. 21. – P. 10453-10462.</mixed-citation><mixed-citation xml:lang="en">Sharma N., Vacher J., Allison J. P. TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion // Proceedings of the National Academy of Sciences. – 2019. – Т. 116. – Vol. 21. – P. 10453-10462.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Scott A. M., Allison J. P., Wolchok J. D. Monoclonal antibodies in cancer therapy // Cancer immunity. – 2012. – Т. 12. – P. 14.</mixed-citation><mixed-citation xml:lang="en">Scott A. M., Allison J. P., Wolchok J. D. Monoclonal antibodies in cancer therapy // Cancer immunity. – 2012. – Т. 12. – P. 14.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Miyajima M. et al. Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior // Nature immunology. – 2017. – Т. 18. – Vol. 12. – P. 1342-1352.</mixed-citation><mixed-citation xml:lang="en">Miyajima M. et al. Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior // Nature immunology. – 2017. – Т. 18. – Vol. 12. – P. 1342-1352.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Fan A. Y. et al. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis // Journal of integrative medicine. – 2020. – Т. 18. – Vol. 5. – P. 385-394</mixed-citation><mixed-citation xml:lang="en">Fan A. Y. et al. Chinese herbal medicine for COVID-19: Current evidence with systematic review and meta-analysis // Journal of integrative medicine. – 2020. – Т. 18. – Vol. 5. – P. 385-394</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Wei S. C., Duffy C. R., Allison J. P. Fundamental mechanisms of immune checkpoint blockade therapy // Cancer discovery. – 2018. – Т. 8. – Vol. 9. – P. 1069-1086.</mixed-citation><mixed-citation xml:lang="en">Wei S. C., Duffy C. R., Allison J. P. Fundamental mechanisms of immune checkpoint blockade therapy // Cancer discovery. – 2018. – Т. 8. – Vol. 9. – P. 1069-1086.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Beatty G. L., Li Y., Long K. B. Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists // Expert review of anticancer therapy. – 2017. – Т. 17. – Vol. 2. – P. 175-186.</mixed-citation><mixed-citation xml:lang="en">Beatty G. L., Li Y., Long K. B. Cancer immunotherapy: activating innate and adaptive immunity through CD40 agonists // Expert review of anticancer therapy. – 2017. – Т. 17. – Vol. 2. – P. 175-186.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Liu M. et al. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47− mediated ‘don’t-eat-me’signal // Nature immunology. – 2019. – Т. 20. – Vol. 3. – P. 265-275.</mixed-citation><mixed-citation xml:lang="en">Liu M. et al. Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47− mediated ‘don’t-eat-me’signal // Nature immunology. – 2019. – Т. 20. – Vol. 3. – P. 265-275.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Long K. B., Collier A. I., Beatty G. L. Macrophages: key orchestrators of a tumor microenvironment defined by therapeutic resistance //Molecular immunology. – 2019. – Vol. 110. – P. 3-12.</mixed-citation><mixed-citation xml:lang="en">Long K. B., Collier A. I., Beatty G. L. Macrophages: key orchestrators of a tumor microenvironment defined by therapeutic resistance //Molecular immunology. – 2019. – Vol. 110. – P. 3-12.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Koike N. The Role of Stem Cells in the Hepatobiliary System and in Cancer Development: a Surgeon’s Perspective. Stem Cells and Cancer in Hepatology. – Academic Press. – 2018. – P. 211-253.</mixed-citation><mixed-citation xml:lang="en">Koike N. The Role of Stem Cells in the Hepatobiliary System and in Cancer Development: a Surgeon’s Perspective. Stem Cells and Cancer in Hepatology. – Academic Press. – 2018. – P. 211-253.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bouwstra R., van Meerten T., Bremer E. CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies // Clinical and Translational Medicine. – 2022. – Т. 12. – Vol. 8. – P. 943. – DOI: 10.1002/ctm2.943.</mixed-citation><mixed-citation xml:lang="en">Bouwstra R., van Meerten T., Bremer E. CD47-SIRPα blocking-based immunotherapy: Current and prospective therapeutic strategies // Clinical and Translational Medicine. – 2022. – Т. 12. – Vol. 8. – P. 943. – DOI: 10.1002/ctm2.943.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Yang H., Xun Y., You H. The landscape overview of CD47-based immunotherapy for hematological malignancies // Biomarker Research. – 2023. – Т. 11. – Vol. 1. – P. 15.</mixed-citation><mixed-citation xml:lang="en">Yang H., Xun Y., You H. The landscape overview of CD47-based immunotherapy for hematological malignancies // Biomarker Research. – 2023. – Т. 11. – Vol. 1. – P. 15.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Hai Z. et al. CD47 as a promising therapeutic target in oncology // Frontiers in Immunology. – 2022. – Р. 4609.</mixed-citation><mixed-citation xml:lang="en">Hai Z. et al. CD47 as a promising therapeutic target in oncology // Frontiers in Immunology. – 2022. – Р. 4609.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Long K. B., Beatty G. L. Harnessing the antitumor potential of macrophages for cancer immunotherapy // Oncoimmunology. – 2013. – Т. 2. – Vol. 12. – P. 26860.</mixed-citation><mixed-citation xml:lang="en">Long K. B., Beatty G. L. Harnessing the antitumor potential of macrophages for cancer immunotherapy // Oncoimmunology. – 2013. – Т. 2. – Vol. 12. – P. 26860.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Anwar M. A. et al. Recent clinical trends in Tolllike receptor targeting therapeutics // Medicinal research reviews. – 2019. – Т. 39. – Vol. 3. – P. 1053-1090.</mixed-citation><mixed-citation xml:lang="en">Anwar M. A. et al. Recent clinical trends in Tolllike receptor targeting therapeutics // Medicinal research reviews. – 2019. – Т. 39. – Vol. 3. – P. 1053-1090.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Krieg A. M. Antiinfective applications of toll-like receptor 9 agonists // Proceedings of the American Thoracic Society. – 2007. – Т. 4. – Vol. 3. – P. 289-294.</mixed-citation><mixed-citation xml:lang="en">Krieg A. M. Antiinfective applications of toll-like receptor 9 agonists // Proceedings of the American Thoracic Society. – 2007. – Т. 4. – Vol. 3. – P. 289-294.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Bezemer G. F. G., Garssen J. TLR9 and COVID-19: a multidisciplinary theory of a multifaceted therapeutic target // Frontiers in Pharmacology. – 2021. – Vol. 11. – P. 601-685. / Rajpoot S. et al. TIRAP in the Mechanism of Inflammation // Frontiers in immunology. – 2021. – Vol. 12. – Article No. 697588.</mixed-citation><mixed-citation xml:lang="en">Bezemer G. F. G., Garssen J. TLR9 and COVID-19: a multidisciplinary theory of a multifaceted therapeutic target // Frontiers in Pharmacology. – 2021. – Vol. 11. – P. 601-685. / Rajpoot S. et al. TIRAP in the Mechanism of Inflammation // Frontiers in immunology. – 2021. – Vol. 12. – Article No. 697588.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Lai C. Y. et al. Natural modulators of endosomal toll-like receptor-mediated psoriatic skin inflammation // Journal of immunology research. – 2017. – Article ID 7807313. – DOI: 10.1155/2017/7807313.</mixed-citation><mixed-citation xml:lang="en">Lai C. Y. et al. Natural modulators of endosomal toll-like receptor-mediated psoriatic skin inflammation // Journal of immunology research. – 2017. – Article ID 7807313. – DOI: 10.1155/2017/7807313.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Shepard C. R. TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism // Frontiers in endocrinology. – 2021. – Т. 11. – P. 613-639.</mixed-citation><mixed-citation xml:lang="en">Shepard C. R. TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism // Frontiers in endocrinology. – 2021. – Т. 11. – P. 613-639.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Sun S. et al. Neutrophil extracellular traps impair intestinal barrier functions in sepsis by regulating TLR9-mediated endoplasmic reticulum stress pathway // Cell Death &amp; Disease. – 2021. – Т. 12. – Vol. 6. – P. 606.</mixed-citation><mixed-citation xml:lang="en">Sun S. et al. Neutrophil extracellular traps impair intestinal barrier functions in sepsis by regulating TLR9-mediated endoplasmic reticulum stress pathway // Cell Death &amp; Disease. – 2021. – Т. 12. – Vol. 6. – P. 606.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Schmitt A. K. et al. Vitamin D3 and zinc synergistically induce regulatory T cells and suppress interferon-γ production in mixed lymphocyte culture // The Journal of Nutritional Biochemistry. – 2022. – Vol. 102. – Article No. 108942.</mixed-citation><mixed-citation xml:lang="en">Schmitt A. K. et al. Vitamin D3 and zinc synergistically induce regulatory T cells and suppress interferon-γ production in mixed lymphocyte culture // The Journal of Nutritional Biochemistry. – 2022. – Vol. 102. – Article No. 108942.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Плавинский С. Л., Шабалкин П. И. Клинико-экономическая эффективность интерферонагамма в комбинации с химиотерапией в лечении распространенной и метастатической меланомы кожи // Профилактическая и клиническая медицина. – 2020. – №. 1. – С. 58-63.</mixed-citation><mixed-citation xml:lang="en">Plavinskii, S. L., Shabalkin, P. I. (2020). Klinikojekonomicheskaja jeffektivnost' interferonagamma v kombinacii s himioterapiej v lechenii rasprostranennoj i metastaticheskoj melanomy kozhi. Preventive and clinical medicine, 1, 58-63. (In Russion).</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wu J., Waxman D. J. Immunogenic chemotherapy: dose and schedule dependence and combination with immunotherapy // Cancer letters. – 2018. – Vol. 419. – P. 210-221</mixed-citation><mixed-citation xml:lang="en">Wu J., Waxman D. J. Immunogenic chemotherapy: dose and schedule dependence and combination with immunotherapy // Cancer letters. – 2018. – Vol. 419. – P. 210-221</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Montamat G. et al. CpG adjuvant in allergenspecific immunotherapy: finding the sweet spot for the induction of immune tolerance // Frontiers in Immunology. – 2021. – Vol. 12. – Article No. 590054. – DOI: 10.3389/fimmu.2021.590054.</mixed-citation><mixed-citation xml:lang="en">Montamat G. et al. CpG adjuvant in allergenspecific immunotherapy: finding the sweet spot for the induction of immune tolerance // Frontiers in Immunology. – 2021. – Vol. 12. – Article No. 590054. – DOI: 10.3389/fimmu.2021.590054.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Артамонов А. В. Средство, обладающее гемостимулирующей активностью, и способ его получения. Патент. – 2018.</mixed-citation><mixed-citation xml:lang="en">Artamonov, A. V. 2018. Sredstvo, obladajushhee gemostimulirujushhej aktivnost'ju, i sposob ego poluchenija. The patent. (In Russion).</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Francescangeli F. et al. COVID-19–Induced modifications in the tumor microenvironment: do they affect cancer reawakening and metastatic relapse? // Frontiers in oncology. – 2020. – Vol. 10. – Article No. 592891. – DOI: 10.3389/fonc.2020.592891.</mixed-citation><mixed-citation xml:lang="en">Francescangeli F. et al. COVID-19–Induced modifications in the tumor microenvironment: do they affect cancer reawakening and metastatic relapse? // Frontiers in oncology. – 2020. – Vol. 10. – Article No. 592891. – DOI: 10.3389/fonc.2020.592891.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Costa T. J. et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage // Vascular pharmacology. – 2022. – Vol. 142. – Article No. 106946.</mixed-citation><mixed-citation xml:lang="en">Costa T. J. et al. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage // Vascular pharmacology. – 2022. – Vol. 142. – Article No. 106946.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Sun Y. et al. ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes // Redox biology. – 2020. – Vol. 37. – Article No. 101696. – DOI: 10.1016/j.redox.2020.101696</mixed-citation><mixed-citation xml:lang="en">Sun Y. et al. ROS systems are a new integrated network for sensing homeostasis and alarming stresses in organelle metabolic processes // Redox biology. – 2020. – Vol. 37. – Article No. 101696. – DOI: 10.1016/j.redox.2020.101696</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Proskurina A. S. et al. Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage IIIV breast cancer // BMC cancer. – 2015. – Т. 15. – Vol. 1. – P. 1-17.</mixed-citation><mixed-citation xml:lang="en">Proskurina A. S. et al. Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune response in patients with stage IIIV breast cancer // BMC cancer. – 2015. – Т. 15. – Vol. 1. – P. 1-17.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Jerne N. K. Idiotypic networks and other preconceived ideas // Immunological reviews. – 1984. – Vol. 79. – P. 5-24.</mixed-citation><mixed-citation xml:lang="en">Jerne N. K. Idiotypic networks and other preconceived ideas // Immunological reviews. – 1984. – Vol. 79. – P. 5-24.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Liu T. et al. The protective effects of shikonin on hepatic ischemia/reperfusion injury are mediated by the activation of the PI3K/Akt pathway // Scientific Reports. – 2017. – Т. 7. – Vol. 1. – Article No. 44785.</mixed-citation><mixed-citation xml:lang="en">Liu T. et al. The protective effects of shikonin on hepatic ischemia/reperfusion injury are mediated by the activation of the PI3K/Akt pathway // Scientific Reports. – 2017. – Т. 7. – Vol. 1. – Article No. 44785.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Guo H. et al. Shikonin attenuates acetaminopheninduced acute liver injury via inhibition of oxidative stress and inflammation // Biomedicine &amp; Pharmacotherapy. – 2019. – Vol. 112. – Article No. 108704.</mixed-citation><mixed-citation xml:lang="en">Guo H. et al. Shikonin attenuates acetaminopheninduced acute liver injury via inhibition of oxidative stress and inflammation // Biomedicine &amp; Pharmacotherapy. – 2019. – Vol. 112. – Article No. 108704.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Qian S. et al. Therapeutic effect of Shaoyao-Gancao Decoction on TLR9-mediated NETosis in MRL/lpr mice // Clinical and Experimental Immunology. – 2023. – Т. 211. – Vol. 2. – P. 184-191</mixed-citation><mixed-citation xml:lang="en">Qian S. et al. Therapeutic effect of Shaoyao-Gancao Decoction on TLR9-mediated NETosis in MRL/lpr mice // Clinical and Experimental Immunology. – 2023. – Т. 211. – Vol. 2. – P. 184-191</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Youn H. S. et al. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex // The Journal of Immunology. – 2005. – Т. 175. – Vol. 5. – P. 3339-3346.</mixed-citation><mixed-citation xml:lang="en">Youn H. S. et al. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex // The Journal of Immunology. – 2005. – Т. 175. – Vol. 5. – P. 3339-3346.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Baltabekov N.T., Chesare M. New approaches to diagnostics and medical rehabilitation of malignant neoplasms at the Primary Health Care (PHC) level: International project report. Oncology and Radiology of Kazakhstan. – 2019. – Т.54 – Vol. 4 – P. 12-19.</mixed-citation><mixed-citation xml:lang="en">Baltabekov N.T., Chesare M. New approaches to diagnostics and medical rehabilitation of malignant neoplasms at the Primary Health Care (PHC) level: International project report. Oncology and Radiology of Kazakhstan. – 2019. – Т.54 – Vol. 4 – P. 12-19.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Panov SA et al. Integrative Approach to the Activation of Macrophages in Medical Rehabilitation of Oncological Patients After Chemo And Chemoradiotherapy // IJDMSR Journal. – 2024. – Vol. 6. P. 473-488.</mixed-citation><mixed-citation xml:lang="en">Panov SA et al. Integrative Approach to the Activation of Macrophages in Medical Rehabilitation of Oncological Patients After Chemo And Chemoradiotherapy // IJDMSR Journal. – 2024. – Vol. 6. P. 473-488.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Yang Z. et al. Immunopathology of terminal complement activation and complement C5 blockade creating a pro-survival and organprotective phenotype in trauma // British Journal of Pharmacology. – 2023. – Т. 180. – Vol. 4. – P. 422-440.</mixed-citation><mixed-citation xml:lang="en">Yang Z. et al. Immunopathology of terminal complement activation and complement C5 blockade creating a pro-survival and organprotective phenotype in trauma // British Journal of Pharmacology. – 2023. – Т. 180. – Vol. 4. – P. 422-440.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Sari D. P. et al. Cytotoxic and antiproliferative activity of polyisoprenoids in seventeen mangroves species against WiDr colon cancer cells // Asian Pacific Journal of Cancer Prevention: APJCP. – 2018. – Т. 19. – Vol. 12. – P. 3393.</mixed-citation><mixed-citation xml:lang="en">Sari D. P. et al. Cytotoxic and antiproliferative activity of polyisoprenoids in seventeen mangroves species against WiDr colon cancer cells // Asian Pacific Journal of Cancer Prevention: APJCP. – 2018. – Т. 19. – Vol. 12. – P. 3393.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Турсунова Н.В., Клинникова М.Г., Торнуев Ю.В., Лушникова Е.Л. Растительные полипренолы как перспективный класс соединений, стимулирующих регенераторные процессы // Современные проблемы науки и образования. – 2019. – № 4. – URL: https://science-education.ru/ru/article/view?id=28977 (Дата обращения: 10.06.2024).</mixed-citation><mixed-citation xml:lang="en">Tursunova, N. V., Klinnikova, M. G., Tornuev, Yu. V., Lushnikova, E. L. (2019). Rastitel'nye poliprenoly kak perspektivnyj klass soedinenij, stimulirujushhih regeneratornye processy. Modern problems of science and education. Retrieved 10, June 2024, 4, from https://science-education.ru/ru/article/view?id=28977. (In Russion).</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Лаптева Е. Н. и др. Полипренолы в клинической практике // Гастроэнтерология Санкт-Петербурга. – 2018. – № 2. – С. 7-14.</mixed-citation><mixed-citation xml:lang="en">Lapteva, E. N. Et al. (2018). Poliprenoly v klinicheskoj praktike. Gastroenterology of St. Petersburg, 2, 7-14. (In Russion). (In Russion).</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Zheng R. et al. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer’s disease by regulating microbiome via network pharmacology and molecular docking analysis // Frontiers in Cellular and Infection Microbiology. – 2023. – Vol. 13. – P. 283.</mixed-citation><mixed-citation xml:lang="en">Zheng R. et al. Molecular mechanisms of Huanglian Jiedu decoction in treating Alzheimer’s disease by regulating microbiome via network pharmacology and molecular docking analysis // Frontiers in Cellular and Infection Microbiology. – 2023. – Vol. 13. – P. 283.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Chen L. Y. et al. Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients // Oncotarget. – 2017. – Т. 8. – Vol. 18. – Article No. 30471.</mixed-citation><mixed-citation xml:lang="en">Chen L. Y. et al. Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients // Oncotarget. – 2017. – Т. 8. – Vol. 18. – Article No. 30471.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Bao D. et al. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression // Oncogene. – 2019. – Т. 38. – Vol. 25. – P. 5007-5020.</mixed-citation><mixed-citation xml:lang="en">Bao D. et al. Mitochondrial fission-induced mtDNA stress promotes tumor-associated macrophage infiltration and HCC progression // Oncogene. – 2019. – Т. 38. – Vol. 25. – P. 5007-5020.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Al‑Harras M. F. et al. Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility // Oncology letters. – 2016. – Т. 11. – Vol. 3. – P. 2182-2188.</mixed-citation><mixed-citation xml:lang="en">Al-Harras M. F. et al. Polymorphisms of glutathione S-transferase π 1 and toll-like receptors 2 and 9: Association with breast cancer susceptibility // Oncology letters. – 2016. – Т. 11. – Vol. 3. – P. 2182-2188.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Bhaskar S., Helen A. Quercetin modulates tolllike receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats // Molecular and cellular biochemistry. – 2016. – Vol. 423. – P. 53-65.</mixed-citation><mixed-citation xml:lang="en">Bhaskar S., Helen A. Quercetin modulates tolllike receptor-mediated protein kinase signaling pathways in oxLDL-challenged human PBMCs and regulates TLR-activated atherosclerotic inflammation in hypercholesterolemic rats // Molecular and cellular biochemistry. – 2016. – Vol. 423. – P. 53-65.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Horvath S. DNA methylation age of human tissues and cell types // Genome biology. – 2013. – Vol. 14. – P. 1-20.</mixed-citation><mixed-citation xml:lang="en">Horvath S. DNA methylation age of human tissues and cell types // Genome biology. – 2013. – Vol. 14. – P. 1-20.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Ahadi S. et al. Personal aging markers and ageotypes revealed by deep longitudinal profiling // Nature Medicine. – 2020. – Т. 26. – Vol. 1. – P. 83-90.</mixed-citation><mixed-citation xml:lang="en">Ahadi S. et al. Personal aging markers and ageotypes revealed by deep longitudinal profiling // Nature Medicine. – 2020. – Т. 26. – Vol. 1. – P. 83-90.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Holtze S. et al. Alternative animal models of aging research // Frontiers in Molecular Biosciences. – 2021. – Vol. 8. – Article No. 660959.</mixed-citation><mixed-citation xml:lang="en">Holtze S. et al. Alternative animal models of aging research // Frontiers in Molecular Biosciences. – 2021. – Vol. 8. – Article No. 660959.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Fraiz G. M. et al. Can resveratrol modulate sirtuins in obesity and related diseases? A systematic review of randomized controlled trials // European Journal of Nutrition. – 2021. – Vol. 60. – P. 2961-2977.</mixed-citation><mixed-citation xml:lang="en">Fraiz G. M. et al. Can resveratrol modulate sirtuins in obesity and related diseases? A systematic review of randomized controlled trials // European Journal of Nutrition. – 2021. – Vol. 60. – P. 2961-2977.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Matkarimov B. T., Saparbaev M. K. Chargaff’s second parity rule lies at the origin of additive genetic interactions in quantitative traits to make natural selection possible // BioRxiv. – 2023. – Vol. 11. – Article No. 16671. – DOI: 10.7717/peerj.16671.</mixed-citation><mixed-citation xml:lang="en">Matkarimov B. T., Saparbaev M. K. Chargaff’s second parity rule lies at the origin of additive genetic interactions in quantitative traits to make natural selection possible // BioRxiv. – 2023. – Vol. 11. – Article No. 16671. – DOI: 10.7717/peerj.16671.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Han D. et al. The emerging role of long noncoding RNAs in tumor-associated macrophages // Journal of Cancer. – 2019. – Vol. 10(26). – P. 6738-6746. – DOI: 10.7150/jca.35770.</mixed-citation><mixed-citation xml:lang="en">Han D. et al. The emerging role of long noncoding RNAs in tumor-associated macrophages // Journal of Cancer. – 2019. – Vol. 10(26). – P. 6738-6746. – DOI: 10.7150/jca.35770.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Israël M., Schwartz L. Tumor Cells are Vitally Dependent upon Ketolysis, Inhibition of Succinyl CoA: 3-Oxoacid-CoA Transferase Should Block Them // Open Access Journal of Biomedical Science. – 2020. – Vol. 1 (5). – P. 220-226.</mixed-citation><mixed-citation xml:lang="en">Israël M., Schwartz L. Tumor Cells are Vitally Dependent upon Ketolysis, Inhibition of Succinyl CoA: 3-Oxoacid-CoA Transferase Should Block Them // Open Access Journal of Biomedical Science. – 2020. – Vol. 1 (5). – P. 220-226.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Israël M., Berg E., Tenenbaum G. Cancer Metabolism: Fasting Reset, the Keto-Paradox and Drugs for Undoing // Journal of Clinical Medicine. – 2023. – Т. 12. – Vol. 4. – P. 1589.</mixed-citation><mixed-citation xml:lang="en">Israël M., Berg E., Tenenbaum G. Cancer Metabolism: Fasting Reset, the Keto-Paradox and Drugs for Undoing // Journal of Clinical Medicine. – 2023. – Т. 12. – Vol. 4. – P. 1589.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Liu M., Kalbasi A., Beatty G. L. Functio laesa: Cancer inflammation and therapeutic resistance // Journal of oncology practice. – 2017. – Т. 13. – Vol. 3. – P. 173-180.</mixed-citation><mixed-citation xml:lang="en">Liu M., Kalbasi A., Beatty G. L. Functio laesa: Cancer inflammation and therapeutic resistance // Journal of oncology practice. – 2017. – Т. 13. – Vol. 3. – P. 173-180.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Панов С. А., Балтабеков Н. Т., Сайдвакасов Р. А. Патент на Полезную Модель № 6180 от 05.02.2021 г. «Способ оценки активности нейтрофилов у онкологических больных». – 2021.</mixed-citation><mixed-citation xml:lang="en">Panov, S. A., Baltabekov, N. T., Saidvakasov, R. A. (2021). Utility Model Patent No. 6180 dated 02/05/2021 «Method for evaluating neutrophil activity in cancer patients». (In Russion).</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Грант КазНИИОиР 2017 «Разработка персонализированной медицинской реабилитации злокачественных новообразований (ЗН) с учетом генетических, иммунологических и функциональных особенностей организма». Выписка из протокола заседания Ученого Совета КазНИИОиР №7 от 12.09.2017. – 2017.</mixed-citation><mixed-citation xml:lang="en">KazIOR grant 2017 «Development of personalized medical rehabilitation of malignant neoplasms (ZN) taking into account the genetic, immunological and functional characteristics of the body». Extract from the minutes of the meeting of the Academic Council of KazIOR No. 7 dated 12.09.2017. (In Russion).</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Научный проект НИ МИПО «Роль нейтрофилов и электробиолюминесценции в лечебном этапе медицинской реабилитации злокачественных новообразований» Выписка из протокола заседания Ученого Совета НИ МИПО №5 от 29.06.22 г. – 2022.</mixed-citation><mixed-citation xml:lang="en">Scientific project of NI MIPO «The role of neutrophils and electrobioluminescence in the therapeutic stage of medical rehabilitation of malignant neoplasms» Extract from the minutes of the meeting of the Scientific Council of NI MIPO No. 5 dated 29/06/22. (In Russion).</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
